Literature DB >> 9529044

Influence of antibodies in mother's milk on antigenic variation of Giardia lamblia in the murine mother-offspring model of infection.

S Stäger1, B Gottstein, H Sager, T W Jungi, N Müller.   

Abstract

In the present study, neonatal ZU.ICR mice and their mothers were infected with trophozoites of Giardia lamblia clone GS/M-83-H7 expressing the variant surface protein (VSP) H7. The infection experiments included a detailed analysis of the specificities of anti-Giardia immunoglobulin A (IgA) antibodies in mother's milk and a determination of the effects of the milk antibodies on both the growth of the parasite during in vitro cultivation and colonization of the parasite within the intestine of suckling offspring. These investigations revealed that transiently emerging milk IgA antibodies against a variant-specific 314-amino-acid N-terminal region of VSP H7 exhibit a strong parasiticidal effect on VSP H7-type trophozoites both in vitro and in vivo. These findings indicated that parasiticidal effects of local IgA antibodies against the N-terminal part of VSP H7 select for new variant types within the intestinal parasite population of suckling mice. The selective influence of such antibodies promotes in vivo antigenic variation of G. lamblia clone GS/M-83-H7 and modulates the early course of parasite infection in these animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529044      PMCID: PMC108051     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  The immune response to Giardia.

Authors:  G M Faubert
Journal:  Parasitol Today       Date:  1996-04

2.  Antigenic variation in Giardia lamblia: infection of congenitally athymic nude and scid mice.

Authors:  B Gottstein; T E Nash
Journal:  Parasite Immunol       Date:  1991-11       Impact factor: 2.280

3.  Cysteine-rich variant surface proteins of Giardia lamblia.

Authors:  A Aggarwal; J W Merritt; T E Nash
Journal:  Mol Biochem Parasitol       Date:  1989-01-01       Impact factor: 1.759

4.  Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile.

Authors:  D B Keister
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

5.  Giardia lamblia infections in B-cell-deficient transgenic mice.

Authors:  S Stager; N Muller
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

6.  Antigenic variation in Giardia lamblia: cellular and humoral immune response in a mouse model.

Authors:  B Gottstein; G R Harriman; J T Conrad; T E Nash
Journal:  Parasite Immunol       Date:  1990-11       Impact factor: 2.280

7.  In vitro synthesized immunoglobulin A from nu/+ and reconstituted nu/nu mice against a dominant surface antigen of Giardia lamblia.

Authors:  B Gottstein; P Deplazes; I Tanner
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

8.  Giardia lamblia infections in adult mice.

Authors:  L G Byrd; J T Conrad; T E Nash
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Purification and measurement of secretory IgA in mouse milk.

Authors:  E L Parr; J J Bozzola; M B Parr
Journal:  J Immunol Methods       Date:  1995-03-27       Impact factor: 2.303

10.  Serological analysis of antigenic heterogeneity of Giardia lamblia variant surface proteins.

Authors:  N Müller; S Stäger; B Gottstein
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

View more
  10 in total

Review 1.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Central importance of immunoglobulin A in host defense against Giardia spp.

Authors:  T Dianne Langford; Michael P Housley; Marianne Boes; Jianzhu Chen; Martin F Kagnoff; Frances D Gillin; Lars Eckmann
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  vsp gene expression by Giardia lamblia clone GS/M-83-H7 during antigenic variation in vivo and in vitro.

Authors:  M Bienz; M Siles-Lucas; P Wittwer; N Müller
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite.

Authors:  Marianne Bienz; Wen Juan Dai; Monika Welle; Bruno Gottstein; Norbert Müller
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

5.  Disruption of antigenic variation is crucial for effective parasite vaccine.

Authors:  Fernando D Rivero; Alicia Saura; Cesar G Prucca; Pedro G Carranza; Alessandro Torri; Hugo D Lujan
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

6.  Experimental infections of neonatal mice with cysts of Giardia lamblia clone GS/M-83-H7 are associated with an antigenic reset of the parasite.

Authors:  N von Allmen; M Bienz; A Hemphill; N Müller
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Arginine deiminase has multiple regulatory roles in the biology of Giardia lamblia.

Authors:  Maria Carolina Touz; Andrea Silvana Rópolo; Maria Romina Rivero; Cecilia Veronica Vranych; John Thomas Conrad; Staffan Gunnar Svard; Theodore Elliott Nash
Journal:  J Cell Sci       Date:  2008-08-12       Impact factor: 5.285

8.  Systemic and mucosal responses to oral administration of excretory and secretory antigens from Giardia intestinalis.

Authors:  Juan Carlos Jiménez; Josette Fontaine; Jean-Marie Grzych; Eduardo Dei-Cas; Monique Capron
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 9.  Comparative Pathobiology of the Intestinal Protozoan Parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum.

Authors:  Andrew Hemphill; Norbert Müller; Joachim Müller
Journal:  Pathogens       Date:  2019-07-29

10.  Serum levels of zinc, copper, vitamin B12, folate and immunoglobulins in individuals with giardiasis.

Authors:  M Zarebavani; D Dargahi; N Einollahi; N Dashti; M Mohebali; M Rezaeian
Journal:  Iran J Public Health       Date:  2012-12-01       Impact factor: 1.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.